Med Tech Talks Podcast
Robert Klupacs, CEO of the Bionics Institute, a world leader in medical device development, talks to leaders, investors, researchers and entrepreneurs in the med tech industry. He delves into their story, who and what motivated them along the way, and their advice to those following a similar path. He also explores the concept of innovation, and what it will take to improve the translation of innovation into commercialisation to change the lives of people living with challenging medical conditions.
Med Tech Talks Podcast
The highs and lows of med tech entrepreneurship with Professor Andrew Wilks and Dr Chris Burns
•
Bionics Institute
•
Season 1
•
Episode 23
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Professor Andrew Wilks and Dr Chris Burns.
Professor Wilks and Dr Burns are two research leaders who were involved in the incredible breakthrough of the drug, Momelotinib, which has emerged as a treatment for myelofibrosis – a rare type of bone marrow cancer.
In this episode you will hear about:
- The journey of momelotinib from bench top to a commercial product
- Professor Wilks and Dr Burns' experience as entrepreneurs
- Where momelotinib is today and the legacy of the Australian research effort.
More information:
Learn more about Professor Andrew Wilks
Find out more about Dr Chris Burns
Updated version 05/08/22
